The mouse model used in this study with CCl4 administered for 1 year underwent severe cholestasis with increased Abcc3 and Abcc4 levels, which corresponds to the findings of previous studies (Jansen et al., 2017; Ghallab et al., 2019b). This evidence concerns the gene ABCC4 and cholestasis.